FIELD: pharmaceutics.
SUBSTANCE: group of inventions relates to a novel derivative of 5'-O-(4-chlorophenoxyacetyl)-N4-hydroxycytidine, as well as to a method for production thereof and use of the compound for inhibiting replication of SARS-CoV-2 coronavirus.
EFFECT: novel compound having high activity against coronavirus SARS-CoV-2 is obtained.
6 cl, 3 ex, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
5'-O-(4-PHENYLBUTANOYL)-N4-HYDROXYCYTIDINE AND USE THEREOF | 2023 |
|
RU2817201C1 |
METHOD FOR OBTAINING 5'-O-(3-PHENYLPROPIONYL)-N4-HYDROXYCYTIDINE | 2022 |
|
RU2791916C1 |
5'-O-(3-PHENYLPROPIONYL)-N4-HYDROXYCYTIDINE AND ITS APPLICATION | 2022 |
|
RU2791523C1 |
USE OF 5'-O-(3-PHENYLPROPIONYL)-N4-HYDROXYCYTIDINE TO INHIBIT INFLUENZA VIRUS REPLICATION IN VITRO AND IN VIVO | 2022 |
|
RU2791806C1 |
URACIL DERIVATIVES WITH ANTIVIRAL ACTIVITY AGAINST SARS-COV-2 | 2021 |
|
RU2769828C1 |
mRNA-BASED VECTOR FOR INCREASED TARGET PROTEIN PRODUCTION IN MAMMALIAN CELLS (VARIANTS) | 2022 |
|
RU2792231C1 |
MODIFIED ANTISENSE OLIGONUCLEOTIDE AGAINST SARS-CoV-2 | 2020 |
|
RU2750584C1 |
APPLICATION OF A TRICYCLIC SULPHUR-CONTAINING DERIVATIVE OF 1,2-DIHYDROQUINOLINE FOR INHIBITING THE REPLICATION OF BETACORONAVIRUSES, INCLUDING SARS-COV-2 | 2021 |
|
RU2780247C1 |
INDOLE-3-CARBOXYLIC ACID DERIVATIVE HAVING ANTIVIRAL ACTIVITY ON SARS-CoV-2 | 2022 |
|
RU2820633C1 |
5,15-BIS(4'-BIS-L-TYROSINYLAMIDOPHENYL)-10,20-BIS(N-METHYLPYRIDINIUM-3'-YL)PORPHIN DIOODIDE, SHOWING THE PROPERTY OF BINDING SARS-COV-2 VIRUS S-PROTEIN | 2022 |
|
RU2784940C1 |
Authors
Dates
2024-04-16—Published
2023-10-18—Filed